Interactions Between Leukotriene C4 and Interleukin 13 Signaling Pathways in a Mouse Model of Airway Disease
Open Access
- 1 April 2006
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 130 (4) , 440-446
Abstract
Context. —During an asthmatic episode, leukotriene C 4 (LTC 4 ) and interleukin 13 (IL-13) are released into the airways and are thought to be central mediators of the asthmatic response. However, little is known about how these molecules interact or affect each other's signaling pathway. Objective. —To determine if the LTC 4 and IL-13 signaling pathways interact with each other's pathways. Design. —We examined airway responsiveness, cysteinyl LTs (Cys-LTs), and Cys-LT and IL-13 receptor transcript levels in wild-type mice and in mice that were deficient in γ-glutamyl leukotrienase (an enzyme that converts LTC 4 to LTD 4 ), STAT6 (signal transducer and activator of transcription 6 [a critical molecule in IL-13 signaling]), and IL-4Rα (a subunit of the IL-13 receptor). Results. —Wild-type (C57BL/129SvEv) and γ-glutamyl leukotrienase–deficient mice showed increased airway responsiveness after intranasal instillation of IL-13; similar results were observed after intranasal instillation of IL-13 or LTC 4 in a second wild-type strain (BALB/c). Interleukin 13 treatment reduced levels of Cys-LTs in bronchoalveolar lavage fluid. This change was unaccompanied by changes in other arachidonic acid metabolites or in RNA transcript levels of enzymes associated with Cys-LT synthesis. Interleukin 13 treatment also increased transcript levels of the Cys-LT 1 and Cys-LT 2 receptors, while LTC 4 increased transcript levels of the α1 chain of the IL-13 receptor. Furthermore, IL-4Rα–deficient mice had increased airway responsiveness to LTC 4 but not to IL-13, whereas STAT6-deficient mice failed to respond to either agonist. Conclusions. —These findings indicate that LTC 4 and IL-13 are dependent on or signal through STAT6 to increase airway responsiveness and that both agonists regulate expression of each other's receptors.Keywords
This publication has 39 references indexed in Scilit:
- The quest for new cysteinyl-leukotriene and lipoxin receptors: recent cluesPharmacology & Therapeutics, 2004
- Signal Transducer and Activator of Transcription 3 Activation by the δ-Opioid Receptor via Gα14 Involves Multiple IntermediatesMolecular Pharmacology, 2004
- Chemokines in asthma: Cooperative interaction between chemokines and IL-13Journal of Allergy and Clinical Immunology, 2003
- Cysteinyl leukotriene receptorsProstaglandins & Other Lipid Mediators, 2002
- Presence of Cysteinyl Leukotrienes in Asthmatic Patients With Chronic SinusitisThe Laryngoscope, 2002
- γ-Glutamyl Leukotrienase, a γ-Glutamyl Transpeptidase Gene Family Member, Is Expressed Primarily in SpleenJournal of Biological Chemistry, 1998
- Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil countsEuropean Respiratory Journal, 1996
- The Immunobiology of EosinophilsNew England Journal of Medicine, 1991
- Plasma Levels of Leukotrienes C4 and D4 during Wheezing Attack in Asthmatic PatientsInternational Archives of Allergy and Immunology, 1987
- Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.Thorax, 1984